Table of Content

Open Access iconOpen Access

ARTICLE

Interferon Gamma Release Assay in response to PE35/PPE68 proteins: a promising diagnostic method for diagnosis of latent tuberculosis

Shima Mahmoudi1, Babak Pourakbari1, Setareh Mamishi1,2

1 Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Infectious Diseases, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

* Corresponding Author: S Mamishi, email

European Cytokine Network 2017, 28(1), 36-40. https://doi.org/10.1684/ecn.2017.0391

Abstract

Tuberculosis control relies on the identification and preventive treatment of people who are latently infected with Mycobacterium tuberculosis (Mtb). PE/PPE proteins have been reported to elicit CD4 and/or CD8 responses either in the form of whole recombinant proteins or as individual peptides. Very few of the PE and PPE proteins have been previously tested for responses in patients with TB and healthy donors. This is the first study to evaluate the Interferon Gamma Release Assay (IGRA) after stimulation with PE35 and PPE68. The antigen-specific levels of IFN-γ following stimulation with QuantiFERON-TB gold in-tube (QFT-G-IT) antigens, and PE35 and PPE68 recombinant proteins were evaluated in 79 children and 102 adults, respectively. Using QFT-G-IT kit, latent tuberculosis infection (LTBI) was detected in 26 children (33%) and 41 adults (40%); IGRA following stimulation with PE35 and PPE68 recombinant proteins, was positive, respectively, in 36 (46%) and 32 (40.5%) children, respectively. In addition, 53 adults (52%) had positive results following stimulation with these two proteins. The sensitivity and specificity of IGRA following stimulation with recombinant PE35 in children were 76% and 80%, and following stimulation with recombinant PPE68 in this group, it was 73% and 75%, respectively. Meanwhile, there is no gold standard test for LTBI. Our designed tests using PE35 and PPE68 PE/PPE proteins, two PE/PPE proteins not present in BCG vaccins, which elicit CD4 and/or CD8 responses, might be helpful for rapid diagnosis of TB and improve the detection of LTBI. However, further validation studies to determine the advantage of IGRAs using these proteins, alone or combined, are highly recommended.

Keywords

Interferon Gamma Release Assay, diagnostic method, PE35, PPE68

Cite This Article

APA Style
Mahmoudi, S., Pourakbari, B., Mamishi, S. (2017). Interferon Gamma Release Assay in response to PE35/PPE68 proteins: a promising diagnostic method for diagnosis of latent tuberculosis. European Cytokine Network, 28(1), 36–40. https://doi.org/10.1684/ecn.2017.0391
Vancouver Style
Mahmoudi S, Pourakbari B, Mamishi S. Interferon Gamma Release Assay in response to PE35/PPE68 proteins: a promising diagnostic method for diagnosis of latent tuberculosis. Eur Cytokine Network. 2017;28(1):36–40. https://doi.org/10.1684/ecn.2017.0391
IEEE Style
S. Mahmoudi, B. Pourakbari, and S. Mamishi, “Interferon Gamma Release Assay in response to PE35/PPE68 proteins: a promising diagnostic method for diagnosis of latent tuberculosis,” Eur. Cytokine Network, vol. 28, no. 1, pp. 36–40, 2017. https://doi.org/10.1684/ecn.2017.0391



cc Copyright © 2017 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 19

    View

  • 15

    Download

  • 0

    Like

Share Link